• 생물환경조절학회지
• /
• 제21권3호
• /
• pp.163-169
• /
• 2012

관비재배 및 수경재배시 비료를 녹일 때 소요되는 시간과 노동력을 절감하고, 작업의 안전성 확보와 자동화를 가능하게 할 수 있는 장치의 개발을 위해 본 실험을 실시하였다. 실험은 세 종류로 수행되었다. 먼저, 효과적인 비료용해 방법을 구명하기 위해 수중펌프를 양액 통 속에 두고 양액 통의 입구에 삼베포를 깐 거름망을 설치하여 물을 스프레이하여 비료를 녹이는 방법(Spray), 수중프로펠러를 이용하는 방법(Propeller), 수중펌프를 양액 통 속에 넣어 물의 흐름을 만들어 주는 방법(Submerged), 에어컴프레서를 이용하여 양액 통 속에 공기흐름을 만들어 비료를 용해하는 방법(Airflow) 등 4개의 처리를 두고 실험하였다. Spray 처리에서 가장 시간이 짧게 소요되는 것으로 조사되었으나 농가가 실제로 적용하는데 어려움이 있어서, Spray 처리 다음으로 비료를 녹이는 시간이 짧고, 노동력을 절감할 수 있으며 양액제조 과정을 자동화 하는 것이 용이할 것으로 사료되는 Airflow 처리를 선택하였다. 두 번째 실험에서는 Airflow 처리에서 사용한 재질과 분지관수를 개선한 6지관 및 8지관 장치를 제작하여 비교 실험했는데, 6지관 장치가 비료용해시간이 짧고, 양액탱크의 입구 크기에 관계없이 사용이 가능하며, 제작이 용이하여 가장 효과적인 장치로 판단되었다. 세 번째 실험에서는 개발된 6지관 장치를 이용하여 비료를 용해하는데 소요되는 시간을 조사하여 경제성을 분석하였는데, 농가에서 수중펌프를 이용하여 비료를 용해하는 방법보다 시간은 1/8배 절약할 수 있으며 경제성이 큰 것으로 나타났다. 아울러 $KNO_3$, $Ca(NO_3)_2{\cdot}4H_2O$, Fe-EDTA 등의 용해특성을 조사했다.

• 대한방사선치료학회지
• /
• 제22권1호
• /
• pp.11-18
• /
• 2010

목 적: 방사선 치료에서 매번 치료를 시행할 때마다 호흡에 의한 해부학적인 내부 장기의 움직임과 환자자세의 변화에 따라 치료부위 오차가 발생한다. 이런 치료부위 오차의 발생은 치료부위와 정상 조직 간의 선량분포의 변화에 영향을 줄 수 있는 원인이 된다. 간암 환자 치료 시 Body-fix의 사용 유무 차이에 따른 임상치료에서의 유용성을 알아보고자 한다. 대상 및 방법: 본원에서 2009년 10월부터 2010년 7월까지 Hi-Art Tomotherapy를 시행 받은 55~60세 사이의 남자환자 중에서 간의 Couinaud 분류 중 V~VI 구역에서 간세포성 암(Hepatocellular carcinoma)이 발생한 환자 10명을 대상으로 Body-fix 사용 유무에 따라 2 그룹으로 분류하여 조사하였다. Body-Fix를 사용 시 진공펌프(Vacuum pump, Medical intelligence, Germany)를 이용하여 80 mbar의 압력으로 진공상태를 유지하였다. 환자는 정상호흡(free breathing)을 유지한 상태에서 바로누운자세(supine position)로 치료 시작부터 5회 치료 시 획득한 MV-CT (Megavoltage computed tomograpy, MVCT)와 KV-CT(Kilovoltage computed tomograpy, KVCT)을 융합하여 일치시키는 작업 후 X축의 좌우방향(Right to Left, RL), Y축의 상하방향(Craniocaudal, CC), Z축의 전후방향(Anterioposterior, AP)에서의 발생하는 방사선 치료 준비오차를 측정하여 비교 분석하였다. 결 과: 영상융합을 통한 평균 방사선 치료 준비오차는 A 그룹에서 $0.3{\pm}1.1\;mm$ (상하), $-1.1{\pm}0.7\;mm$ (좌우), $-0.2{\pm}0.7\;mm$ (전후)이었다. B 그룹에서는 $0.62{\pm}1.94\;mm$ (상하), $-3.62{\pm}1.5\;mm$ (좌우), $-0.22{\pm}1.2\;mm$ (전후)로 이동하였다. 두 그룹간의 Body-fix의 사용유무에 따른 X축, Y축, Z축 방향의 편차는 최대 X축(좌우) 5.5 mm, Y축(상하) 19.8 mm, Z축(전후) 3.2 mm로 측정되었다. 또한 오차방향의 분석과 관련하여 모든 환자에 일관성이 존재하지는 않지만 Body-Fix를 사용 시 매일 환자자세 변화와 호흡변화가 발생함에도 불구하고 방사선 치료 준비오차에 대한 위치 변화가 안정적인 양상의 결과를 보여준다. 결 론: 간암 환자 치료 시 Body-Fix의 사용은 방사선 치료 준비오차가 환자자세와 호흡변화에도 불구하고 각 그룹간의 편차가 발생하는 가운데에 안정적이며 규칙적이므로 Tomotherapy와 같은 고 정밀 치료에 효과적으로 사용되리라 사료된다.

• 한국항공우주학회지
• /
• 제41권3호
• /
• pp.226-232
• /
• 2013

소형 무인항공기의 동력장치로 연료전지 시스템을 적용하기 위해 화학수소화합물 수소 저장방법을 이용한 소형 수소 발생 제어장치를 설계하였다. 효율이 높은 소형/경량 수소 발생 제어장치를 설계하기 위하여 $NaBH_4$ 수용액 공급 유량에 따른 Co-B 촉매의 수소 전환율을 확인하였고, 100W 스택의 최대 수소 발생량에 적합한 Co-B 촉매양을 제안하였다. 효율적인 연료 소모를 위해 Dead-end 방식의 스택을 선택하였고, 수소 발생 제어장치 내부 압력을 이용한 펌프 on/off 제어로 수소 생성량을 제어하였다. 소형 수소 발생 제어장치를 이용한 연료전지 시스템의 각 작동구간에서 안정된 운전을 확인하였다. 장시간 운전 실험을 통하여 최대 7시간 운전이 가능하며, 임의의 비행 프로화일에 요구되는 추력 프로화일은 최소 4시간 이상 조정 가능함을 확인하였다.

• 수산해양기술연구
• /
• 제36권3호
• /
• pp.166-174
• /
• 2000

멸치초망용 챗대의 유압 권양장치를 개발하기 위하여 모형 챗대와 그물을 실물의 1/5크기로 제작하여 챗대를 권양할 때의 장력을 측정하고, 이를 토대로 권양기 3종을 설계 제작하여 그 성능을 시험한 결과를 요약하면 다음과 같다. 1. 챗대를 건양하는데 가장 큰 장력이 작용할 때는 챗대 끝이 수면 하 4m에 있을 때이었고, 이 때 챗대줄에 작용하는 장력은 187.5kgf이었다. 2. 멸치초망 어업에 적합한 권양기의 조건은 어탐중 챗대가 움직이지 않아야 하며, 그 방법으로 감속기나 전자브레이크를 장치하는 것보다 시간 경과에 따른 누수량이 적은 것을 사용하는 것이 바람직하였다. 3. 시험에 사용된 권양기 중 최적의 권양기에 있어서 압력차 $\Delta$P를 130kgf/$\textrm{cm}^2$으로 고정하였을 때, 권양기에 감겨지는 챗대줄의 권양속도는 2m/sec로서 재래식 방법보다 0.48m/sec 빠르게 나타났으며, 양망당 약 1.6톤의 멸치를 어획할 수 있다. 4. 권양기 2대를 설치함으로써 조업인원 2명을 절감할 수 있었다.

• Journal of Chest Surgery
• /
• 제9권2호
• /
• pp.220-238
• /
• 1976

Six cases of congenital heart disease were operated on by means of cardiopulmonary bypass between December, 1975 and April, 1976. Two cases of ventricular septal defects (VSD), two cases of VSD, associated with ruptured aneurysm of sinus Valsalva, two cases of atrial septal defects (ASD) and one case of pulmonic stenosis with patent ductus arteriosus were operated. Sarns roller pumps and Bentley Temptrol oxygenators were used for extracorporeal circulation. Pump oxygenator was primed with Ringer's lactate solution, 5% dextrose in water, mannitol, and ACD blood. Flow rate ranged from 2.0 to $2.4L/M^2/min$. Bicarbonate was added to the oxygenator with estimated amount as 15 mEq/L/hr. Venous catheters were introduced into superior and inferior vena cava, and oxygenated blood was returned to the body through aortic cannula inserted into ascending aorta. Moderate hypothermia ($30^{\circ}C$) was induced by core cooling. Aorta was cross clamped for 15 minutes and released for 3 minutes, and repeated clamping when necessary. Atrial and ventricular septal efects were closed by direct sutures. Aneurysms of sinus Valsalva ruptured into the right ventricle were repaired through right ventriculotomy by d:rect closure with Dacron patch reinforcement. Cardiopulmonary bypass time varied from 66 to 209 minutes, and aorta cross clamping time ranged from 13 to 56 minutes. Postoperative bleeding was minimal except one case who needed for evacuation of substernal hematoma. Intra- and postoperative urinary output was satisfactory. Acid-base balance, partial pressure of $O_2$, electrolytes, and hematological changes during intra- and post-perfusion period remained at the acceptable ranges. No mortality was experienced.

• Journal of Chest Surgery
• /
• 제24권2호
• /
• pp.123-134
• /
• 1991

Twenty eight patients had undergone repair of an isolated complete atrioventricular septal defect between April 1986 and September 1990 in Seoul National University Children`s Hospital. The group comprised 13 male and 15 female patients. They ranged in age from 2 months to 8 years[mean 18.6months] and in weight from 3. 4kg to 23kg[mean 9.0$\pm$4.6kg]. They were analysed as Rastelli type A in 17 patients, Rastelli type B in 2 patients, and Rastelli type C in 9 patients. Seven patients had concomitant Down`s syndrome. All patients had large left-to-right shunt[mean pulmonary to systemic flow ratio 3.5 $\pm$2.2 ranging from 0.68 to 10.0] and high pulmonary systolic pressure[mean 74$\pm$18.8mmHg, ranging from 35 to 110]. In 11 patients, one patch technique was used to close the atrial and ventricular septal defect and 16 patients were undergone by two patch technique. We urgently managed only one patient by pulmonary artery banding whose anatomy was Rastelli type C and severe mitral regurgitation was identified. Postoperative complete A - V block was noted in 3 patients, two of whom were dead in operating room due to combined LVOTO and myocardial failure, and one patient with Rastelli type C was undergone by VVI type permanent pacemaker insertion 1wk later after two patch technique, but we had to manage him by modified Konno operation and total correction due to LVOTO and VSD leakage and severe mitral regurgitation 3 years later. Another two reoperation cases due to severe mitral regurgitation after two patch technique were undergone, one of whom we managed by mitral annuloplasty 3 months later but aggravated mitral regurgitation made us to control him by MVR 3 months later. Another one case of VSD leakage and tricuspid regurgitation was managed by total correction but she died of respiratory insufficiency 14 days later. We experienced pulmonary hypertensive crisis in 3 patients, who were dead in two cases comparing with one control case. So operative mortality is 9/27[33.6%], in one patch group of 3/11[29.2%] comparing with two patch group of 6/16[37.5%]. In summary, causes of death were pump weaning failure, myocardial failure and low cardiac output syndrome and pulmonary hypertensive crisis, resp. failure, complete AV block. Mean follow up period is 15.8$\pm$10.7 months[ranging from 3months to 37 months]

• 대한기계학회논문집A
• /
• 제39권5호
• /
• pp.543-547
• /
• 2015

고강도 철근을 생산하기 위해서는 템프코어(Tempcore)라고 불리는 냉각 공정이 적용되고 있는데, 템프코어를 이용하면 합금원소를 첨가하지 않고 Mild steel 로부터 강도 및 용접성이 우수한 철근을 생산 할 수 있다. 하지만 현장 설비를 이용하여 다양한 냉각 조건과 화학성분 변경의 영향을 평가하기에는 한계가 있다. 따라서, 본 연구에서는 템프코어 공정을 모사하기 위한 장치를 개발하였으며, 이를 이용하여 경화된 표층부, 중간영역, 연한 내부 조직으로 이루어진 템프코어 조직을 구현하였다. 실험장치는 현장 설비와 동일한 Cooler 1 기가 장착되었고, 12~13 bar 의 압력과 최대 $50m^3/h$의 유량을 공급하는 펌프라인으로 구성되어 있다. 항복강도를 기준으로 400 MPa 이상을 요구하는 강종인 SD400 모사 결과 경화층 면적비 및 냉각 깊이 별 경도가 제품과 잘 일치함을 알 수 있었다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제9권2호
• /
• pp.87-94
• /
• 2005

It is not clear whether $Ca^{2+}-induced$ $Ca^{2+}$ release from the sarcoplasmic reticulum (SR) is involved in the regulation of atrial natriuretic peptide (ANP) release. Previously, we have shown that nifedipine increased ANP release, indicating that $Ca^{2+}$ entry via voltage-gated L-type $Ca^{2+}$ channel activation decreases ANP release. The purpose of the present study was two-fold: to define the role of SR $Ca^{2+}$ release in the regulation of ANP release and whether $Ca^{2+}$ entry via L-type $Ca^{2+}$ channel is prerequisite for the SR-related effect on ANP release. Experiments were performed in perfused beating rabbit atria. Ryanodine, an inhibitor of SR $Ca^{2+}$ release, increased atrial myocytic ANP release ($8.69{\pm}3.05$, $19.55{\pm}1.09$, $27.31{\pm}3.51$, and $18.91{\pm}4.76$% for 1, 2, 3, and $6{\mu}M$ ryanodine, respectively; all P<0.01) with concomitant decrease in atrial stroke volume and pulse pressure in a dose-dependent manner. In the presence of thapsigargin, an inhibitor of SR $Ca^{2+}$ pump, ryanodine-induced increase in ANP release was not observed. Thapsigargin attenuated ryanodine-induced decrease in atrial dynamic changes. Blockade of L-type $Ca^{2+}$ channel with nifedipine abolished ryanodine-induced increase in ANP release ($0.69{\pm}5.58$% vs. $27.31{\pm}3.51$%; P＜0.001). In the presence of thapsigargin and ryanodine, nifedipine increased ANP release and decreased atrial dynamics. These data suggest that $Ca^{2+}$-induced $Ca^{2+}$ release from the SR is inversely involved in the regulation of atrial myocytic ANP release.

• 대한한방내과학회지
• /
• 제37권1호
• /
• pp.90-108
• /
• 2016

Objectives: This study aimed to learn what should be considered in the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD) by analyzing the existing guidelines and clinical trials.Methods: The development committee searched the existing guidelines for herbal medicinal products or GERD. Then, clinical trials related to GERD using herbal medicine were selected. The chosen trials were analyzed in terms of their inclusion and exclusion of participants, intervention, comparators, outcome, and trial design. Then, we compared the results of the analysis according to the regulations and guidelines of the Ministry of Food and Drug Safety to suggest the issues that we will have to consider when developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).Results: As a result, few guidelines for GERD and clinical trials with herbal medicinal products were located in the national institution homepage. In addition, 8 articles were found using the following combination of search terms: “Gastroesophageal reflux disease”, “GERD”, “herbal medicine”, “herbal therapy”, “Korean Medicine”, “Traditional Chinese Medicine”, and “TCM”. Even though all trials had their own unique research questions, all studies were performed using a randomization method. Most trials included participants with reflux esophagitis, but two trials targeted proton pump inhibitor-refractory GERD. The type of intervention varied, such as decoction, granules, and capsules. Additionally, individualized herbal medicines were used in two studies. Comparators were diverse, such as placebo, Western medicine, and electro-acupuncture. The most frequently used outcome for efficacy was the effectiveness rate. In addition, the outcome for evaluating quality of life, esophageal mucosa and pressure, esophageal acid reflux, and recurrence rates were used. Safety was investigated by recording adverse events and carrying out laboratory tests.Conclusions: We identified some issues by reviewing the existing guidelines and comparing them with clinical trials for GERD and herbal medicinal products. These results will be utilized for developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).

• 대한치과마취과학회지
• /
• 제14권4호
• /
• pp.213-219
• /
• 2014

Background: Clinical use of propofol along with remifentanil for intravenous sedation is increasing in these days, but there are not enough researches to evaluate proper target concentration when these drugs are infused by using target controlled infusion (TCI) pump in dental treatment cases. In this study, we compared efficacy of TCI conscious sedation and target concentration of propofol when it used with or without remifentanil during conscious sedation with the help of a TCI for the surgical extraction of impacted teeth. Methods: After IRB approval, all the charts of patients who had undergone surgical extraction of impacted teeth under propofol TCI sedation for 6 months were selected and reviewed for this study. After reviewal of charts, we could divide patients in two groups. In one group (group 1), only propofol was selected for sedation and initial effect site concentration of propofol was $1{\mu}g/ml$ (n = 33), and in another group (group 2), both propofol and remifentanil was infused and initial effect site concentration of each drug was $0.6{\mu}g/ml$ and 1 ng/ml respectively (n = 25). For each group, average propofol target concentration was measured. In addition, we compared heart rate, respiratory rate, and systolic and diastolic blood pressure as well as oxygen saturation. Besides, BIS, sedation scores (OAAS/S), and subjective satisfaction scores were compared. Results: Between group 1 and 2, there were no significant differences in demographics (age, weight and height), and total sedation time. However, total infused dose and the effect site target concentration of propofol was $163.8{\pm}74.5mg$ and $1.13{\pm}0.21{\mu}g/ml$ in group 1, and $104.3{\pm}46.5mg$ and $0.72{\pm}0.26{\mu}g/ml$ in the group 2 with $1.02{\pm}0.21ng/l$ of the effect site target concentration of remifentanil, respectively. During sedation, there were no differences between overall vital sign, BIS and OAAS/S in 2 groups (P > 0.05). However, we figured out patients in group 2 had decreased pain sensation during sedation. Conclusions: Co-administration of propofol along with remifentanil via a TCI for the surgical extraction of impacted teeth may be safe and effective compared to propofol only administration.